In last trading session, Tango Therapeutics Inc (NASDAQ:TNGX) saw 0.55 million shares changing hands with its beta currently measuring 0.80. Company’s recent per share price level of $2.36 trading at -$0.07 or -2.88% at ring of the bell on the day assigns it a market valuation of $253.51M. That closing price of TNGX’s stock is at a discount of -409.32% from its 52-week high price of $12.02 and is indicating a premium of 0.42% from its 52-week low price of $2.35.
For Tango Therapeutics Inc (TNGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.11. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Tango Therapeutics Inc (NASDAQ:TNGX) trade information
Upright in the red during last session for losing -2.88%, in the last five days TNGX remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $2.36 price level, adding 12.59% to its value on the day. Tango Therapeutics Inc’s shares saw a change of -23.62% in year-to-date performance and have moved -5.98% in past 5-day. Tango Therapeutics Inc (NASDAQ:TNGX) showed a performance of -23.38% in past 30-days.
Wall Street analysts have assigned a consensus price target of 18 to the stock, which implies a rise of 86.89% to its current value. Analysts have been projecting 18 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would drop -662.71% in reaching the projected high whereas dropping to the targeted low would mean a loss of -662.71% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around -11.20% while estimates for its earnings growth in next 5 years are of -10.57%.
Tango Therapeutics Inc (NASDAQ:TNGX)’s Major holders
TRV GP IV, LLC is the top institutional holder at TNGX for having 19.2 million shares of worth $164.75 million. And as of 2024-06-30, it was holding 17.7276 of the company’s outstanding shares.
The second largest institutional holder is ECOR1 CAPITAL, LLC, which was holding about 13.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.3075 of outstanding shares, having a total worth of $114.38 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.03 shares of worth $4.79 million or 1.89% of the total outstanding shares. The later fund manager was in possession of 1.33 shares on Nov 30, 2024 , making its stake of worth around $3.14 million in the company or a holder of 1.24% of company’s stock.
